CHIEF SCI OFCR, OPHTHALMOLOGY
Avg Cost/Share
$10.64
Shares
27,659
Total Value
$294,291.76
Owned After
613,187
SEC Form 4
CHIEF SCI OFCR, OPHTHALMOLOGY
Avg Cost/Share
$14.38
Shares
27,659
Total Value
$409,470.22
Owned After
613,187
CHIEF DEV. OFFICER
Avg Cost/Share
$9.36
Shares
27,661
Total Value
$258,906.96
Owned After
613,187
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Naylor Stuart | MGTX | CHIEF SCI OFCR, OPHTHALMOLOGY | Oct 6, 2026 | Sell | $10.64 | 27,659 | $294,291.76 | 613,187 | |
| Naylor Stuart | MGTX | CHIEF SCI OFCR, OPHTHALMOLOGY | Jul 7, 2026 | Sell | $14.38 | 27,659 | $409,470.22 | 613,187 | |
| Naylor Stuart | MGTX | CHIEF DEV. OFFICER | Apr 7, 2026 | Sell | $9.36 | 27,661 | $258,906.96 | 613,187 |